» Articles » PMID: 18336867

Clinical Implications of the Basic Defects in Cockayne Syndrome and Xeroderma Pigmentosum and the DNA Lesions Responsible for Cancer, Neurodegeneration and Aging

Overview
Journal Mech Ageing Dev
Specialty Geriatrics
Date 2008 Mar 14
PMID 18336867
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer, aging, and neurodegeneration are all associated with DNA damage and repair in complex fashions. Aging appears to be a cell and tissue-wide process linked to the insulin-dependent pathway in several DNA repair deficient disorders, especially in mice. Cancer and neurodegeneration appear to have complementary relationships to DNA damage and repair. Cancer arises from surviving cells, or even stem cells, that have down-regulated many pathways, including apoptosis, that regulate genomic stability in a multi-step process. Neurodegeneration however occurs in nondividing neurons in which the persistence of apoptosis in response to reactive oxygen species is, itself, pathological. Questions that remain open concern: sources and chemical nature of naturally occurring DNA damaging agents, especially whether mitochondria are the true source; the target tissues for DNA damage and repair; do the human DNA repair deficient diseases delineate specific pathways of DNA damage relevant to clinical outcomes; if naturally occurring reactive oxygen species are pathological in human repair deficient disease, would anti-oxidants or anti-apoptotic agents be feasible therapeutic agent?

Citing Articles

Elf1 promotes Rad26's interaction with lesion-arrested Pol II for transcription-coupled repair.

Sarsam R, Xu J, Lahiri I, Gong W, Li Q, Oh J Proc Natl Acad Sci U S A. 2024; 121(3):e2314245121.

PMID: 38194460 PMC: 10801861. DOI: 10.1073/pnas.2314245121.


The Multifaceted Syndromic Primary Immunodeficiencies in Children.

Ng K, Goenka A, Manyika F, Bernatoniene J J Clin Med. 2023; 12(15).

PMID: 37568366 PMC: 10419544. DOI: 10.3390/jcm12154964.


The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies.

Sarasin A Cancers (Basel). 2023; 15(10).

PMID: 37345043 PMC: 10216379. DOI: 10.3390/cancers15102706.


Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.

Nikolaev S, Yurchenko A, Sarasin A Orphanet J Rare Dis. 2022; 17(1):104.

PMID: 35246173 PMC: 8896305. DOI: 10.1186/s13023-022-02203-1.


UV Protection in the Cornea: Failure and Rescue.

Volatier T, Schumacher B, Cursiefen C, Notara M Biology (Basel). 2022; 11(2).

PMID: 35205145 PMC: 8868636. DOI: 10.3390/biology11020278.


References
1.
Garland F, Garland C, Gorham E, Young J . Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990; 19(6):614-22. DOI: 10.1016/0091-7435(90)90058-r. View

2.
Barlow C, Dennery P, Shigenaga M, Smith M, Morrow J, Roberts 2nd L . Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci U S A. 1999; 96(17):9915-9. PMC: 22310. DOI: 10.1073/pnas.96.17.9915. View

3.
Hayashi M, Araki S, Kohyama J, Shioda K, Fukatsu R . Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain Dev. 2005; 27(1):34-8. DOI: 10.1016/j.braindev.2004.04.001. View

4.
Gueven N, Luff J, Peng C, Hosokawa K, Bottle S, Lavin M . Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant. Free Radic Biol Med. 2006; 41(6):992-1000. DOI: 10.1016/j.freeradbiomed.2006.06.018. View

5.
Heidrick M, Hendricks L, Cook D . Effect of dietary 2-mercaptoethanol on the life span, immune system, tumor incidence and lipid peroxidation damage in spleen lymphocytes of aging BC3F1 mice. Mech Ageing Dev. 1984; 27(3):341-58. DOI: 10.1016/0047-6374(84)90057-5. View